Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

GSK holding history

GSK plc in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
4,374
Value
$229.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,374$229.3K<0.1%−480−9.9%ReducedHolders
Q1 20264,854$267.9K<0.1%+480+11.0%AddedHolders
Q4 20254,374$214.5K<0.1%00.0%UnchangedHolders
Q3 20254,374$188.8K<0.1%+384+9.6%AddedHolders
Q2 20253,990$153.2K<0.1%+2,682+205.0%AddedHolders
Q1 20251,308$50.7K<0.1%+580+79.7%AddedHolders
Q4 2024728$24.6K<0.1%00.0%UnchangedHolders
Q3 2024728$29.8K<0.1%00.0%UnchangedHolders
Q2 2024728$28.0K<0.1%−181−19.9%ReducedHolders
Q1 2024909$39.0K<0.1%00.0%UnchangedHolders
Q4 2023909$33.7K<0.1%−360−28.4%ReducedHolders
Q3 20231,269$46.0K<0.1%−128−9.2%ReducedHolders
Q2 20231,397$49.8K<0.1%−640−31.4%ReducedHolders
Q1 20232,037$72.5K<0.1%−39−1.9%ReducedHolders
Q4 20222,076$73.0K<0.1%−693−25.0%ReducedHolders
Q3 20222,769$81.0K<0.1%−1,347−32.7%ReducedHolders
Q2 20224,116$179.0K<0.1%+299+7.8%AddedHolders
Q1 20223,817$166.0K<0.1%00.0%UnchangedHolders
Q4 20213,817$168.0K<0.1%00.0%UnchangedHolders
Q3 20213,817$146.0K<0.1%−710−15.7%ReducedHolders
Q2 20214,527$180.0K<0.1%−50−1.1%ReducedHolders
Q1 20214,577$163.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.